EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Bacterial Biofilms in Antimicrobial Resistance: Emerging Therapeutic Approaches and Clinical Challenges

Stella Georgiou, Marios Ipeirotis, Aliki Peletidi, Georgios Rallis, Konstantinos Liaras

Bacteria · 02.11.2026 · 5 (4) · 68

DOI: 10.3390/bacteria5040068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bacteria, online erschienen am 02.11.2026. Verfasst von Stella Georgiou und 4 weiteren Autor:innen. Die Arbeit nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial biofilms are sessile microbial communities, and their inherent resistance to antimicrobials is the main cause of many persistent and chronic infections. Their complex and heterogeneous status provides conditions that may contribute to the emergence and dissemination of antimicrobial resistance. In this review, we examine the contribution of biofilms to antimicrobial resistance, and we provide an overview of emerging therapies designed to prevent, disrupt, or eliminate biofilm-associated infections. We also focus on studies published between 2021 and 2026, with earlier seminal studies considered where relevant to providing any necessary scientific context. Emphasis was placed on quorum sensing inhibitors, anti-virulence strategies, matrix-disrupting agents, bacteriophage-based approaches, and combination therapies with conventional antimicrobials. These approaches may produce promising antibiofilm effects in experimental and preclinical models, while their clinical value may be enhanced when combined with conventional antibiotics. However, challenges remain in translating these findings into clinical practice. Successful clinical implementation of antibiofilm therapies will depend on evidence of clinical benefit, together with reliable evaluation, manufacturing standards, and multidisciplinary care. Future research should focus on clinically relevant experimental models and well-designed studies to clarify the effectiveness of these approaches and identify the patient populations and clinical settings in which they may offer therapeutic benefit.

Zitieren

APA

Georgiou, S., Ipeirotis, M., Peletidi, A., Rallis, G., & Liaras, K. (2026). Targeting Bacterial Biofilms in Antimicrobial Resistance: Emerging Therapeutic Approaches and Clinical Challenges. Bacteria, 5(4), 68. https://doi.org/10.3390/bacteria5040068

Vancouver

Georgiou S, Ipeirotis M, Peletidi A, Rallis G, Liaras K. Targeting Bacterial Biofilms in Antimicrobial Resistance: Emerging Therapeutic Approaches and Clinical Challenges. Bacteria. 2026;5(4):68. doi:10.3390/bacteria5040068

BibTeX
@article{Georgiou2026,
  author = {Georgiou, Stella and Ipeirotis, Marios and Peletidi, Aliki and Rallis, Georgios and Liaras, Konstantinos},
  title = {Targeting Bacterial Biofilms in Antimicrobial Resistance: Emerging Therapeutic Approaches and Clinical Challenges},
  journal = {Bacteria},
  year = {2026},
  volume = {5},
  number = {4},
  pages = {68},
  doi = {10.3390/bacteria5040068}
}
Kostenlos starten →